CD8A and Sezary syndrome: <h4>Background</h4>Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL) with distinct clinical and biological features compared to rarer entities such as primary cutaneous CD8<sup>+</sup> aggressive epidermotropic cytotoxic T-cell lymphoma (PCAECTCL).